Follow-up of COVID-19 Vaccine-related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary.

Moy, Linda; Kim, Eric

Moy, Linda; Kim, Eric.

Moy L; From the Department of Radiology, Center for Biomedical Imaging, Center for Advanced Imaging Innovation and Research, New York University Grossman School of Medicine, Laura and Isaac Perlmutter Cancer Center, 160 E 34th St, 3rd Floor, New York, NY 10016.
Kim E; From the Department of Radiology, Center for Biomedical Imaging, Center for Advanced Imaging Innovation and Research, New York University Grossman School of Medicine, Laura and Isaac Perlmutter Cancer Center, 160 E 34th St, 3rd Floor, New York, NY 10016.

Radiology ; 305(1): 54-55, 2022 10.

Article in English | MEDLINE | ID: covidwho-1807537

Subject(s)

COVID-19; Lymphadenopathy; COVID-19 Vaccines/adverse effects; Follow-Up Studies; Humans; Longitudinal Studies; Lymphadenopathy/diagnostic imaging; Lymphadenopathy/etiology; Prospective Studies; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphadenopathy / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Radiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google